Govt grants linked to rogue US company, fishy float treats investors like mushrooms, tax overkill increasing business costs
What's in your National Business Review print edition this week.
Hot Topic
EARNINGS
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
In NBR Print today: US investors have been warned not to trade shares in a company that received New Zealand government grants worth $312,000. Therapy Cells, Inc has securities listed on the OTC “Pink Sheet” market in the US but the stock ticker is covered by a “stop sign” and a warning that the company may not be making material information available to the marketplace. Duncan Bridgeman reports.
“Overkill” is how one tax expert describes Inland Revenue’s latest proposed response to the global crackdown on multinational tax avoidance. Rob Hosking looks at the IRD’s long-awaited options paper for dealing with "hybrid" financial instruments.
New Zealand’s geographic isolation appears to have fostered a certain style of thinking in its security community. How can a problem like the future of national security and intelligence be solved without clear agreement either on what most threatens New Zealand, or even what constitutes security? Nathan Smith reports.
Macquarie has issued a bearish commentary on Fonterra’s Chinese dairy foods partner Beingmate, assessing its value as half that paid by Fonterra in March last year. “The poor results reaffirm our cautious view on China’s infant milk formula (IMF) market,” Macquarie says. Tim Hunter reports.
Three high-profile venture capitalists have successfully sued a software company they poured money into some 12 years ago. They and other certain shareholders now have a priority over any dividends the company declares, up to $3.1 million, which the company says could result in it becoming insolvent. Campbell Gibson reports.
Retail investors are going to be kept in the dark on the book-building process setting the final price of the New Zealand King Salmon float, writes Shoeshine.
The death of a well-known rich-lister has prompted a squabble between two prominent families over a $250,000 loan and racing publication The Informant, reports Karyn Scherer.
All this and more in today’s NBR Print Edition. Out now
Click the hamburger symbol top right of our homepage to access the Rich List 2016 and other sections.
Staff Reporter
Fri, 09 Sep 2016
Fri, 09 Sep 2016
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Free News Alerts
Sign up to get the latest stories and insights delivered to your inbox – free, every day.
Govt grants linked to rogue US company, fishy float treats investors like mushrooms, tax overkill increasing business costs
61496